Pluristem Therapeutics (PSTI) to Deliver Two Presentations During Israel's Largest Biotech Conference: IATI-BioMed
6/10/2013 9:41:16 AM
More...
|
FDA Puts Pluristem Therapeutics (PSTI) Muscle Pain Drug Study on Clinical Hold
6/4/2013 9:47:54 AM
More...
|
Pluristem Therapeutics (PSTI) to Present at FDA Symposium
5/29/2013 9:57:24 AM
More...
|
Pluristem Therapeutics (PSTI) Welcomes Parliamentary State Secretary of the German Federal Ministry for Environmental, Nature Conservation and Nuclear Safety and the Chairman of the Charite Berlin-Brandenburg Center for Regenerative Therapies
5/22/2013 9:33:18 AM
More...
|
Pluristem Therapeutics (PSTI) Release: Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia
5/13/2013 9:34:49 AM
More...
|
Pluristem Therapeutics (PSTI) Develops PLX-RAD Cells for Use in Hematology
5/7/2013 9:48:50 AM
More...
|
Third Party Research Study Demonstrates Pluristem Therapeutics (PSTI)'s PLX-PAD Cells' Safety in Human Lung Models of Pulmonary Hypertension
4/29/2013 11:46:40 AM
More...
|
Pluristem Therapeutics (PSTI) Obtains Orphan Drug Status for Aplastic Anemia Treatment
2/21/2013 7:13:33 AM
More...
|
Pluristem Therapeutics (PSTI) Takes Possession of and Moving Into New State-of-the-Art Manufacturing Facility
1/30/2013 9:30:05 AM
More...
|
Pluristem Therapeutics (PSTI) Updates Cell Manufacturing Industry on Its Proprietary 3D Cell Expansion Technology at Industry Conference
1/22/2013 9:10:52 AM
More...
|
|